ArticleCancers2019

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma.

Xianqiong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.